BioCentury
ARTICLE | Financial News

Roka sets IPO range

July 9, 2014 1:17 AM UTC

Molecular diagnostics play Roka Bioscience Inc. (Warren, N.J.) amended its NASDAQ IPO and now plans to sell 5 million shares at $14-$16. At the $15 midpoint, the company would raise $75 million and be...